Class II
Terminated
Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% sterile, 3.5 g tube, RX only, Manufactured by Allergan, Irvine, California, 92612, U.S.A., NDC: 0023-0313-0…
Why: Failed Impurities/Degradation Specifications: stability testing results did not meet the specification for impurities.
- Company
- Allergan Sales, LLC
Waco, TX, United States - Reported
- Jul 5, 2017
- Recall started
- May 1, 2017
- Ended
- May 1, 2019
- Where sold
- Nationwide in the US
- Amount
- 648 units
- Full product description
- Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% sterile, 3.5 g tube, RX only, Manufactured by Allergan, Irvine, California, 92612, U.S.A., NDC: 0023-0313-04.
- Lots / codes affected
- Lot: 93802, EXP NOV 2019
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.